Special Issue "Pathways to Psychological Resilience in Breast Cancer Survivorship"

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Psychosocial Oncology".

Deadline for manuscript submissions: 1 November 2021.

Special Issue Editor

Prof. Dr. Nazanin Derakshan
E-Mail Website
Guest Editor
Centre for Building Resilience in Breast Cancer (BRiC), Department of Psychological Sciences, Birkbeck University of London, London WC1E 7HX, UK
Interests: Emotional vulnerability in breast cancer; resilience; anxiety; depression; cognitive function; neurocognitive training; neuroscience

Special Issue Information

Dear Colleagues,

Breast cancer is the biggest cause of cancer, and the biggest malignancy in women worldwide. Recent reviews (Wang et al., 2020) highlight that anxiety and depression can independently predict cancer recurrence and cancer specific mortality in breast cancer respectively, with depression increasing risk of mortality by 30%. There is an urgent need to understand the underlying mechanisms behind emotional and cognitive vulnerability in this population and implement resilience-based interventions to improve quality of life.

This special issue will bring together research from a range of methods and disciplines, encouraging younger and more established researchers to contribute. It will draw on research investigating mechanisms of emotional vulnerability and resilience in individuals diagnosed with breast cancer, the impact of breast cancer diagnosis and treatment on quality of life and explore interventions that deliver longer term benefits with sustainability.

Prof. Dr. Nazanin Derakshan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • emotional vulnerability
  • breast cancer
  • cognitive function
  • workability, quality of life
  • resilience
  • interventions
  • training
  • survivorship
  • quality of life
  • mixed methods
  • neuroscience

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life
Curr. Oncol. 2021, 28(4), 2452-2465; https://doi.org/10.3390/curroncol28040224 - 02 Jul 2021
Viewed by 673
Abstract
One side-effect of oncological treatment is chemotherapy-induced alopecia (CIA), a temporary form of hair loss that could influence patients’ mental health. Digitised scalp cooling systems are assuming an important role in the clinical setting during adjuvant treatment, promising hair loss prevention and allowing [...] Read more.
One side-effect of oncological treatment is chemotherapy-induced alopecia (CIA), a temporary form of hair loss that could influence patients’ mental health. Digitised scalp cooling systems are assuming an important role in the clinical setting during adjuvant treatment, promising hair loss prevention and allowing an efficient procedure to reinforce patients’ mental health during chemotherapy by avoiding CIA. The present study was carried out through two research protocols: in Research Protocol 1, we conducted a randomised clinical study to evaluate the emotional impact of using scalp cooling technology in women with BC compared with a traditional chemotherapy setting; in Research Protocol 2, we conducted an observational pre-post study involving women with BC diagnosis being under adjuvant chemotherapy in two experimental conditions: no scalp cooling application and scalp cooling application. Seventy-four women undergoing chemotherapy, aged 30–55 years, were enrolled in both research protocols. We investigated oncological patients’ psychological dimensions including body image, body appreciation, expectations, and satisfaction with the scalp cooling treatment, with reference to chemotherapy treatment applying the scalp cooling solution. Our data evidenced the need to implement a supportive clinical approach via brief, tailored psychological intervention addressing patients’ progressive adaptation to chemotherapy adverse events and their concerns regarding induced alopecia and the value of the scalp cooling system. Patients receiving the innovative chemotherapy probably coped with it by neglecting its physical impact, instead focusing on avoiding alopecia by using the technological solution and neglecting the emotional impact of chemotherapy as a severe pharmacological treatment. Full article
(This article belongs to the Special Issue Pathways to Psychological Resilience in Breast Cancer Survivorship)
Show Figures

Figure 1

Back to TopTop